Medical and Diagnostic Imaging Technology Alert. Novel Indicator for Breast Cancer Screening; Next Generation Behavioral Health Platform; Diagnostic and Therapeutic PET Imaging Agent

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This issue profiles a novel indicator for breast cancer screening, a next generation behavioral health platform, and a diagnostic and therapeutic PET imaging agent

Table of Contents

Medical and Diagnostic Imaging Technology Alert. Novel Indicator for Breast Cancer Screening; Next Generation Behavioral Health Platform; Diagnostic and Therapeutic PET Imaging AgentIn This Issue1. NOVEL INDICATOR FOR BREAST CANCER SCREENING2. NEXT GENERATION BEHAVIORAL HEALTH PLATFORM3. DIAGNOSTIC AND THERAPEUTIC PET IMAGING AGENT4. QUANTITATIVE DIAGNOSIS OF CARDIOVASCULAR DISEASES5. VIRTUAL REALITY-BASED INTERACTIVE CLINICAL SOLUTION6. COST-EFFECTIVE AND PORTABLE ROBOTIC SURGERY SYSTEM7. INNOVATIVE PLATFORM FOR ALLERGY TREATMENT8. INNOVATIVE WIRELESS MONITORING SYSTEM9. TECHVISION 2015




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.